126 related articles for article (PubMed ID: 20932115)
1. Role of myeloperoxidase in cardiology.
Ikitimur B; Karadag B
Future Cardiol; 2010 Sep; 6(5):693-702. PubMed ID: 20932115
[TBL] [Abstract][Full Text] [Related]
2. Myeloperoxidase: a leukocyte-derived protagonist of inflammation and cardiovascular disease.
Nussbaum C; Klinke A; Adam M; Baldus S; Sperandio M
Antioxid Redox Signal; 2013 Feb; 18(6):692-713. PubMed ID: 22823200
[TBL] [Abstract][Full Text] [Related]
3. Myeloperoxidase: Its role for host defense, inflammation, and neutrophil function.
Aratani Y
Arch Biochem Biophys; 2018 Feb; 640():47-52. PubMed ID: 29336940
[TBL] [Abstract][Full Text] [Related]
4. The other myeloperoxidase: Emerging functions.
Vanhamme L; Zouaoui Boudjeltia K; Van Antwerpen P; Delporte C
Arch Biochem Biophys; 2018 Jul; 649():1-14. PubMed ID: 29614255
[TBL] [Abstract][Full Text] [Related]
5. Monocytes and neutrophils expressing myeloperoxidase occur in fibrous caps and thrombi in unstable coronary plaques.
Tavora FR; Ripple M; Li L; Burke AP
BMC Cardiovasc Disord; 2009 Jun; 9():27. PubMed ID: 19549340
[TBL] [Abstract][Full Text] [Related]
6. Growing significance of myeloperoxidase in non-infectious diseases.
Hoy A; Leininger-Muller B; Kutter D; Siest G; Visvikis S
Clin Chem Lab Med; 2002 Jan; 40(1):2-8. PubMed ID: 11916266
[TBL] [Abstract][Full Text] [Related]
7. The development of myeloperoxidase inhibitors.
Galijasevic S
Bioorg Med Chem Lett; 2019 Jan; 29(1):1-7. PubMed ID: 30466896
[TBL] [Abstract][Full Text] [Related]
8. The role of myeloperoxidase in the pathogenesis of coronary artery disease.
Nicholls SJ; Hazen SL
Jpn J Infect Dis; 2004 Oct; 57(5):S21-2. PubMed ID: 15507760
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of myeloperoxidase in coronary artery disease: comparison of unstable and stable angina patients.
Roman RM; Camargo PV; Borges FK; Rossini AP; Polanczyk CA
Coron Artery Dis; 2010 May; 21(3):129-36. PubMed ID: 20305551
[TBL] [Abstract][Full Text] [Related]
10. C-reactive protein stimulates myeloperoxidase release from polymorphonuclear cells and monocytes: implications for acute coronary syndromes.
Singh U; Devaraj S; Jialal I
Clin Chem; 2009 Feb; 55(2):361-4. PubMed ID: 19074520
[TBL] [Abstract][Full Text] [Related]
11. The Dual Role of Myeloperoxidase in Immune Response.
Arnhold J
Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33137905
[TBL] [Abstract][Full Text] [Related]
12. The roles of myeloperoxidase in coronary artery disease and its potential implication in plaque rupture.
Teng N; Maghzal GJ; Talib J; Rashid I; Lau AK; Stocker R
Redox Rep; 2017 Mar; 22(2):51-73. PubMed ID: 27884085
[TBL] [Abstract][Full Text] [Related]
13. Myeloperoxidase and cardiovascular disease.
Nicholls SJ; Hazen SL
Arterioscler Thromb Vasc Biol; 2005 Jun; 25(6):1102-11. PubMed ID: 15790935
[TBL] [Abstract][Full Text] [Related]
14. Trans-vessel gradient of myeloperoxidase in coronary artery disease.
Alipour A; Ribalta J; Njo TL; Janssen HW; Birnie E; van Miltenburg AJ; Elte JW; Castro Cabezas M
Eur J Clin Invest; 2013 Sep; 43(9):920-5. PubMed ID: 23869443
[TBL] [Abstract][Full Text] [Related]
15. Intracellular localization of myeloperoxidase in murine peritoneal B-lymphocytes and macrophages.
de Araujo TH; Okada SS; Ghosn EE; Taniwaki NN; Rodrigues MR; de Almeida SR; Mortara RA; Russo M; Campa A; Albuquerque RC
Cell Immunol; 2013 Jan; 281(1):27-30. PubMed ID: 23434459
[TBL] [Abstract][Full Text] [Related]
16. Myeloperoxidase: molecular mechanisms of action and their relevance to human health and disease.
van der Veen BS; de Winther MP; Heeringa P
Antioxid Redox Signal; 2009 Nov; 11(11):2899-937. PubMed ID: 19622015
[TBL] [Abstract][Full Text] [Related]
17. Myeloperoxidase - A bridge linking inflammation and oxidative stress with cardiovascular disease.
Ndrepepa G
Clin Chim Acta; 2019 Jun; 493():36-51. PubMed ID: 30797769
[TBL] [Abstract][Full Text] [Related]
18. Myeloperoxidase and coronary arterial disease: from research to clinical practice.
Roman RM; Wendland AE; Polanczyk CA
Arq Bras Cardiol; 2008 Jul; 91(1):e11-9. PubMed ID: 18660935
[TBL] [Abstract][Full Text] [Related]
19. Serum myeloperoxidase levels and platelet activation parameters as diagnostic and prognostic markers in the course of coronary disease.
Pawlus J; Hołub M; Kozuch M; Dabrowska M; Dobrzycki S
Int J Lab Hematol; 2010 Jun; 32(3):320-8. PubMed ID: 20201999
[TBL] [Abstract][Full Text] [Related]
20. A patent review of myeloperoxidase inhibitors for treating chronic inflammatory syndromes (focus on cardiovascular diseases, 2013-2019).
Soubhye J; Van Antwerpen P; Dufrasne F
Expert Opin Ther Pat; 2020 Aug; 30(8):595-608. PubMed ID: 32510253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
